PDEX Stock Risk & Deep Value Analysis
Pro-Dex Inc
Healthcare • Medical Instruments & Supplies
DVR Score
out of 10
What You Need to Know About PDEX Stock
We analyzed Pro-Dex Inc using our deep value framework. Sign in to see our full verdict and DVR Score.
We ran PDEX through our deep value framework — analyzing financial health, distress signals, competitive moat, and risk factors. Our risk assessment: Moderate. Here's what we found.
How Risky Is PDEX Stock?
Overall Risk
Moderate
Financial Risk
Low
Market Risk
Low
Competitive Risk
Medium
Execution Risk
Medium
Regulatory Risk
Medium
What Are the Red Flags for PDEX?
- ⚠
Loss of a key client contract or significant reduction in orders
- ⚠
Regulatory changes impacting medical device manufacturing costs or approvals
- ⚠
Supply chain disruptions affecting component availability or lead times
Unlock PDEX Red Flags & Risk Warnings
Create a free account to see the full analysis
What Does Pro-Dex Inc (PDEX) Do?
Market Cap
$94.82M
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
179
Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. It offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. The company also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. Its products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.
Visit Pro-Dex Inc WebsiteIs PDEX Stock Undervalued?
Unlock the full AI analysis for PDEX
Get the complete DVR score, risk analysis, and more
Is PDEX Financially Healthy?
P/E Ratio
8.71
Does PDEX Have a Competitive Moat?
Sign in to unlockMoat Rating
🛡️ Narrow
Moat Trend
Stable
Moat Sources
2 Identified
The moat is durable due to the high regulatory hurdles, specialized technical expertise, and significant qualification processes required in medical device manufacturing, creating substantial switching costs for OEM clients.
Moat Erosion Risks
- •Client consolidation leading to increased pricing pressure
- •Technological shifts or disruptive manufacturing processes from competitors
- •Loss of key personnel with specialized technical knowledge
PDEX Competitive Moat Analysis
Sign up to see competitive advantages
What Could Drive PDEX Stock Higher?
Near-Term (0-6 months)
- •Q1 2026 Earnings Report (Estimated Late April / Early May 2026)
- •Announcement of new significant OEM contract wins
Medium-Term (6-18 months)
- •Expansion of existing client contracts with higher volume or new product lines
- •Minor product or process innovation enhancing efficiency/capabilities
Long-Term (18+ months)
- •Sustained growth in medical/dental device outsourcing trends
- •Increased demand for advanced robotic surgical instruments
Catalysts & Growth Drivers
Upgrade to Premium to see catalysts
What's the Bull Case for PDEX?
- ✓
Significant expansion into new, higher-growth medical device sub-segments beyond its current niche
- ✓
Sustained acceleration in revenue growth driven by new, large-scale contracts
- ✓
Deterioration in gross profit margins or loss of major OEM clients
Bull Case Analysis
See what could go right with Premium
Compare PDEX to Similar Stocks
See how Pro-Dex Inc stacks up against related companies in our head-to-head analysis.
📊 Explore More Stock Analysis
Get comprehensive Deep Value Reports for thousands of stocks. Research risk, financial health, and investment potential with our AI-powered analysis.
Important Disclaimer – Not Financial Advice
Deep Value Reports is an independent research platform for educational and informational purposes only. We are not financial advisors, investment advisors, or licensed professionals. The analysis, scores, and information provided on this page for PDEX (Pro-Dex Inc) should not be construed as personalized investment advice, a recommendation to buy or sell any security, or an offer to provide investment advisory services.
All investments involve risk, including the potential loss of principal. Past performance does not guarantee future results. Always conduct your own research, consider your financial situation, and consult with a qualified financial advisor before making any investment decisions.
